Ranked on: #114 Top VC Firms in the Bay Area 2026 (Ranked by Deals) · #158 Most Active Growth Investors of 2026 (Ranked) · Get your badge →
Is this your firm? Get featured or correct your listing →
Strategy
Stages
SeedSeries A
Sectors
HealthcareBiotech
Geographies
USASan Francisco, California, USA
Check size
$1M-$20MRecent changes
- Oct 19, 2026Oct 19, 2026Invested in Nouscom (Series D, €120M) EU-Startups
Portfolio
2 totalRecent Investment Activity
1Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Nouscom | Series D | Participated | €120M | — | M Ventures (Merck KGaA)LeadStartup Ticker · unverifiedEuropean Investment BankStartup Ticker · unverified5AM VenturesStartup Ticker · unverifiedAndera PartnersStartup Ticker · unverifiedBpifranceStartup Ticker · unverifiedVersant VenturesStartup Ticker · unverifiedRevelation PartnersAngelini IndustriesNeva SGRAngelini Ventures+5 more | EU-Startups |
Co-Investors
9Similar Firms
overlapping sector, stage or regionLatest Pulse
- Oct 19, 2026Nouscom Raises $135M To Push Cancer-Prevention Vaccine Toward ApprovalSwiss biotech Nouscom raised $135M (€120M) in a Series D co-led by M Ventures, Merck KGaA's venture arm, and Revelation Partners, to fund a global trial of cancer-prevention vaccine NOUS-209 in Lynch syndrome carriers.→
- Aug 4, 2026Latigo Sets Terms for a $272M Nasdaq IPOLatigo Biotherapeutics set terms for a $272M Nasdaq IPO under ticker LTGO, pricing 16M shares at $16-18 to fund late-stage trials of its non-opioid Nav1.8 pain drug, a rival to Vertex's Journax.→
5AM Ventures FAQ
What companies has 5AM Ventures invested in?
5AM Ventures' portfolio includes Nouscom, Latigo Biotherapeutics.
Who does 5AM Ventures co-invest with most?
In the rounds Value Add tracks, 5AM Ventures most often invests alongside Ascenta Capital (1 shared deal), Blue Owl Capital (1 shared deal), Bpifrance (1 shared deal), Foresite Capital (1 shared deal), M Ventures (Merck KGaA) (1 shared deal).
Sources & methodologyshow
Where these figures come from
- EU-Startupsresearch database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.